Manufacturer of Controlled Substances; Notice of Registration, Norac Inc., 19718 [2012-7750]

Download as PDF 19718 Federal Register / Vol. 77, No. 63 / Monday, April 2, 2012 / Notices Dated: March 23, 2012. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 USC § 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. [FR Doc. 2012–7759 Filed 3–30–12; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration, Norac Inc. By Notice dated December 20, 2011, and published in the Federal Register on December 29, 2011, 76 FR 81979, Norac Inc., 405 S. Motor Avenue, Azusa, California 91702–3232, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: Drug Schedule Dated: March 23, 2012. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2012–7750 Filed 3–30–12; 8:45 am] BILLING CODE 4410–09–P mstockstill on DSK4VPTVN1PROD with NOTICES With regard to Gamma Hydroxybutyric Acid (2010), Tetrahydrocannabinols (7370), and Methamphetamine (1105) only, the company manufactures these controlled substances in bulk solely for domestic distribution within the United States to customers engaged in dosage-form manufacturing. With regard to Nabilone (7379) only, the company presently manufactures a small amount of this controlled substance in bulk solely to conduct manufacturing internal process development. It is the company’s intention once the manufacturing process is refined to the point that its Nabilone bulk product is available for commercial use, the company will export the controlled substance in bulk solely to customers engaged in dosageform manufacturing outside the United States. The company is aware of the requirement to obtain a DEA registration as an exporter to conduct this activity. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Norac, Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Norac, VerDate Mar<15>2010 17:42 Mar 30, 2012 Jkt 226001 Signed at Washington, DC, this 22nd day of March 2012. Elliott S. Kushner, Certifying Officer, Office of Trade Adjustment Assistance. [FR Doc. 2012–7795 Filed 3–30–12; 8:45 am] BILLING CODE 4510–FN–P Employment and Training Administration DEPARTMENT OF LABOR I I II II II All workers from Dow Jones & Company, Inc., Dow Jones Content Services, including on-site workers from Aerotek, Princeton, New Jersey, who became totally or partially separated from employment on or after February 13, 2010, through January 26, 2014, and all workers in the group threatened with total or partial separation from employment on date of certification through two years from the date of certification, are eligible to apply for adjustment assistance under Chapter 2 of Title II of the Trade Act of 1074, as amended. DEPARTMENT OF LABOR [TA–W–81,045] Gamma Hydroxybutyric Acid (2010). Tetrahydrocannabinols (7370) ..... Methamphetamine (1105) ............ Pentobarbital (2270) ..................... Nabilone (7379) ............................ location of Dow Jones & Company, Inc., Dow Jones Content Services. The amended notice applicable to TA–W–81,045 is hereby issued as follows: Dow Jones & Company, Inc., Dow Jones Content Services Including OnSite Workers From Aerotek, Inc., Princeton, NJ; Amended Certification Regarding Eligibility To Apply for Worker Adjustment Assistance In accordance with Section 223 of the Trade Act of 1974, as amended (‘‘Act’’), 19 U.S.C. 2273, the Department of Labor issued a Certification of Eligibility to Apply for Worker Adjustment Assistance on January 26, 2012, applicable to workers of Aerotek, Inc., working on-site at Dow Jones Corporation, Dow Jones Content Services Princeton, New Jersey. The workers are engaged in activities related to the production of digital newsletters. The notice was published in the Federal Register on February 8, 2012 (77 FR 6590). At the request of the New Jersey State agency, the Department reviewed the certification for workers of the subject firm. New information shows that workers of the Princeton, New Jersey location of Dow Jones & Company, Dow Jones Content Services, including onsite workers from Aerotek were engaged in activities supporting the production of digital newsletters, both experienced worker separations during the relevant time period due to the shift in the production of digital newsletters to Sophia, Bulgaria. Accordingly, the Department is amending the certification to include workers of the Princeton, New Jersey PO 00000 Frm 00109 Fmt 4703 Sfmt 4703 Employment and Training Administration [TA–W–81,038] Ford Motor Company Twin Cities Assembly Plant Vehicle Operations Division Including On-Site Leased Workers From AEROTEK, Albers Mechanical, Alliedbarton, Allied Systems Aristeo, Autoport Collins Electric, Guardsmark, Great Western Recycling, Healthsource Solutiions, Kelly Services, Marsden Building Maintenance, Penski Logistics Ppg Industries, Waste Management, VMX, Nascote Industries, Delphi Electronics & Safety, Unicomm, And Pacer International St. Paul, MN; Amended Certification Regarding Eligibility To Apply for Worker Adjustment Assistance In accordance with Section 223 of the Trade Act of 1974, as amended (‘‘Act’’), 19 U.S.C. 2273, the Department of Labor issued a Certification of Eligibility to Apply for Worker Adjustment Assistance on February 9, 2012, applicable to workers of Ford Motor Company, Twin Cities Assembly Plant, Vehicle Operations Division, St. Paul, Minnesota. The workers are engaged in activities related to the production of pickup trucks. The notice was published in the Federal Register on February 28, 2012 (77 FR 12083). At the request of the Minnesota State agency, the Department reviewed the certification for workers of the subject firm. New information from the E:\FR\FM\02APN1.SGM 02APN1

Agencies

[Federal Register Volume 77, Number 63 (Monday, April 2, 2012)]
[Notices]
[Page 19718]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-7750]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration, 
Norac Inc.

    By Notice dated December 20, 2011, and published in the Federal 
Register on December 29, 2011, 76 FR 81979, Norac Inc., 405 S. Motor 
Avenue, Azusa, California 91702-3232, made application by renewal to 
the Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of the following basic classes of controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid (2010)...........  I
Tetrahydrocannabinols (7370)...............  I
Methamphetamine (1105).....................  II
Pentobarbital (2270).......................  II
Nabilone (7379)............................  II
------------------------------------------------------------------------

    With regard to Gamma Hydroxybutyric Acid (2010), 
Tetrahydrocannabinols (7370), and Methamphetamine (1105) only, the 
company manufactures these controlled substances in bulk solely for 
domestic distribution within the United States to customers engaged in 
dosage-form manufacturing.
    With regard to Nabilone (7379) only, the company presently 
manufactures a small amount of this controlled substance in bulk solely 
to conduct manufacturing internal process development. It is the 
company's intention once the manufacturing process is refined to the 
point that its Nabilone bulk product is available for commercial use, 
the company will export the controlled substance in bulk solely to 
customers engaged in dosage-form manufacturing outside the United 
States. The company is aware of the requirement to obtain a DEA 
registration as an exporter to conduct this activity.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Norac, Inc. to manufacture the listed basic classes of controlled 
substances is consistent with the public interest at this time. DEA has 
investigated Norac, Inc. to ensure that the company's registration is 
consistent with the public interest. The investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 USC Sec.  823(a), and in accordance with 21 CFR 1301.33, the 
above named company is granted registration as a bulk manufacturer of 
the basic classes of controlled substances listed.

    Dated: March 23, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2012-7750 Filed 3-30-12; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.